Position in SVTRnew
Snapshot 2026-11-03- Startup SignalsRankedof 2,287
- Life SciencesRankedof 241
- Data GovernanceRankedof 23
About
nPhase (REDCap Cloud / nPhase.ai), founded in 2016 and based in Atlantic Beach, Florida, builds an AI-native clinical data platform that unifies clinical trial and real-world data into a single governed foundation, covering EDC, randomization, ePRO, eConsent, statistical computing and regulatory submission prep for pharma sponsors, CROs, biotechs, academic research organizations and MedTech companies.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Company· 3
Investor· 1
Founders / team· 2
Funding history
- 2026-11-02Series D$30M
Investors · Viking Global InvestorsSource · nphase.ai ↗
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- nPhase
nPhase (REDCap Cloud / nPhase.ai), founded in 2016 and based in Atlantic Beach, Florida…
Series D+ · 2026-11
—
United States
BusinessLatest roundTotal raisedDate- Biobase
Clinical data agent platform: cross-institution clinical data standardization and indexing, AI agent-automated cohort building and data procurement…
— - Cyera
AI-driven data security posture management and identity security platform
Series D+ · $2.7B · 2026-09 · Valuation $12B
$2.7BValuation $12B - Datavant
Healthcare data collaboration platform: secure linkage, de-identification and exchange of medical records across institutions
Strategic · $83M · 2026-09
$83M
China
BusinessLatest roundTotal raisedDateEurope
BusinessLatest roundTotal raisedDate- Agora Labs
On-premises clinical data standardization, anonymization and federated learning infrastructure for hospitals, clinical research centers…
2026-10
— - TietAI
AI-native healthcare data integration and interoperability platform (Hydra) for hospitals and healthcare providers
— - Prevalent AI
Security data fabric and knowledge graph platform for large enterprises, providing trusted enterprise context for security operations and AI agents.
Undisclosed · $22M · 2026-08
$22M
Other / unspecified
BusinessLatest roundTotal raisedDateConfirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Y Combinator
39 Life Sciences deals in the last 24 months · 3 at a nearby stage · 32 in United States
Request intro →General Catalyst
38 Life Sciences deals in the last 24 months · 7 at a nearby stage · 34 in United States
Request intro →Andreessen Horowitz
22 Life Sciences deals in the last 24 months · 9 at a nearby stage · 20 in United States
Request intro →Khosla Ventures
21 Life Sciences deals in the last 24 months · 6 at a nearby stage · 20 in United States
Request intro →Thrive Capital
18 Life Sciences deals in the last 24 months · 8 at a nearby stage · 15 in United States
Request intro →Lightspeed
16 Life Sciences deals in the last 24 months · 5 at a nearby stage · 14 in United States
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.